Partha Palit1, Nahid Ali. 1. Infectious Diseases and Immunology Division, Indian Institute of Chemical Biology, 4 Raja S. C. Mullick Road, Kolkata 700032, India.
Abstract
OBJECTIVES: This study was executed to investigate the efficacy of oral therapy and preliminary leishmanicidal mechanism of sertraline, a selective serotonin reuptake inhibitor widely used for the management of depression, against Leishmania donovani, a causative agent of visceral leishmaniasis (VL). METHODS: The effect of the drug was determined for: (i) direct promastigote killing by inhibition of MTT reduction and (ii) killing activity against intracellular amastigotes in mouse peritoneal macrophages by microscopic evaluation of surviving amastigotes in macrophages in Giemsa-stained slides. Furthermore, the oral therapy of sertraline against established VL in BALB/c mice was evaluated through estimation of splenic and liver parasite burdens by Leishman Donovan units. Moreover, the preliminary mechanism of action of the drug against promastigotes was assessed by measuring the intracellular ATP levels and oxygen consumption of treated cells. RESULTS: Sertraline killed L. donovani promastigotes and intracellular amastigotes with 50% inhibitory concentrations (IC(50)s) of 2.2 and 2.3 mg/L, respectively. The drug was also effective in eliminating splenic (72%) and liver (70%) parasite loads in infected BALB/c mice through oral therapy. A sertraline-induced fall in cytoplasmic ATP levels and oxygen consumption rate in promastigotes suggests the involvement of an apoptosis mode of cell death in the treated parasites. CONCLUSIONS: Sertraline could be a promising pharmacological tool for the oral treatment of VL.
OBJECTIVES: This study was executed to investigate the efficacy of oral therapy and preliminary leishmanicidal mechanism of sertraline, a selective serotonin reuptake inhibitor widely used for the management of depression, against Leishmania donovani, a causative agent of visceral leishmaniasis (VL). METHODS: The effect of the drug was determined for: (i) direct promastigote killing by inhibition of MTT reduction and (ii) killing activity against intracellular amastigotes in mouse peritoneal macrophages by microscopic evaluation of surviving amastigotes in macrophages in Giemsa-stained slides. Furthermore, the oral therapy of sertraline against established VL in BALB/c mice was evaluated through estimation of splenic and liver parasite burdens by Leishman Donovan units. Moreover, the preliminary mechanism of action of the drug against promastigotes was assessed by measuring the intracellular ATP levels and oxygen consumption of treated cells. RESULTS:Sertraline killed L. donovani promastigotes and intracellular amastigotes with 50% inhibitory concentrations (IC(50)s) of 2.2 and 2.3 mg/L, respectively. The drug was also effective in eliminating splenic (72%) and liver (70%) parasite loads in infected BALB/c mice through oral therapy. A sertraline-induced fall in cytoplasmic ATP levels and oxygen consumption rate in promastigotes suggests the involvement of an apoptosis mode of cell death in the treated parasites. CONCLUSIONS:Sertraline could be a promising pharmacological tool for the oral treatment of VL.
Authors: Marta L Lima; María A Abengózar; Montserrat Nácher-Vázquez; María P Martínez-Alcázar; Coral Barbas; Andre G Tempone; Ángeles López-Gonzálvez; Luis Rivas Journal: Antimicrob Agents Chemother Date: 2018-11-26 Impact factor: 5.191
Authors: Rodrigo Arreola; Enrique Becerril-Villanueva; Carlos Cruz-Fuentes; Marco Antonio Velasco-Velázquez; María Eugenia Garcés-Alvarez; Gabriela Hurtado-Alvarado; Saray Quintero-Fabian; Lenin Pavón Journal: J Immunol Res Date: 2015-04-19 Impact factor: 4.818
Authors: Maiara Maria Romanelli; Thais Alves da Costa-Silva; Edezio Cunha-Junior; Daiane Dias Ferreira; Juliana M Guerra; Andres Jimenez Galisteo; Erika Gracielle Pinto; Leandro R S Barbosa; Eduardo Caio Torres-Santos; Andre Gustavo Tempone Journal: Front Cell Infect Microbiol Date: 2019-10-29 Impact factor: 5.293
Authors: Daiane Dias Ferreira; Juliana Tonini Mesquita; Thais Alves da Costa Silva; Maiara Maria Romanelli; Denise da Gama Jaen Batista; Cristiane França da Silva; Aline Nefertiti Silva da Gama; Bruno Junior Neves; Cleber Camilo Melo-Filho; Maria de Nazare Correia Soeiro; Carolina Horta Andrade; Andre Gustavo Tempone Journal: J Venom Anim Toxins Incl Trop Dis Date: 2018-10-30